From 26-29 September 2018, Mölnlycke was present at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic...

Mölnlycke, a world-leading medical products and solutions company, is pleased to announce its acquisition of M&J Airlaid Products A/S (“M&J”).

The partnership will leverage deep expertise of both companies to improve range and availability of wound care products and solutions across the region

The Swedish medical solutions company, Mölnlycke, is acquiring a patent application from Innovation Skåne, that will help detect infections in wounds....

In August, Mölnlycke was present at the 20th Annual Meeting of the European Pressure Ulcer Advisory Panel (EPUAP) in Rome, Italy. The congress was held ...

Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...

We are pleased to announce the successful closing and signing of a EUR 350,000,000 Multicurrency Revolving Credit Facility (the “Facility”) for Mölnlyck...

The Swedish medical solutions company, Mölnlycke Health Care, today (6 December 2016) announced a licensing agreement  with the Texas-based biomedical R...